Skip to main content

Table 6 Satisfaction with injection

From: Corticosteroid injection for shoulder pain: single-blind randomized pilot trial in primary care

Criteria

Methylprednisolone acetate with lidocaine (n = 19)

Lidocaine (n = 21)

Responses to first satisfaction question at 2 weeks:

  

 No problems at all

1 (5%)

1 (5%)

 Much better

1 (5%)

2 (10%)

 Slightly better

10 (53%)

4 (19%)

 No change

3 (16%)

5 (24%)

 Slightly worse

3 (16%)

7 (33%)

 Much worse

1 (5%)

2 (10%)

Responses to first satisfaction question at 4 weeks:

  

 No problems at all

1 (5%)

2 (10%)

 Much better

5 (26%)

3 (15%)

 Slightly better

4 (21%)

5 (25%)

 No change

6 (32%)

7 (35%)

 Slightly worse

1 (5%)

2 (10%)

 Much worse

2 (11%)

1 (5%)

 Data missing

 

1

Responses to first satisfaction question at 12 weeks:

  

 No problems at all

1 (5%)

1 (5%)

 Much better

5 (26%)

8 (42%)

 Slightly better

3 (16%)

3 (16%)

 No change

8 (42%)

3 (16%)

 Slightly worse

2 (11%)

0 (0%)

 Much worse

0 (0%)

4 (21%)

 Data missing

 

2

Responses to second satisfaction question at 2 weeks:

  

 Very pleased

1 (5%)

2 (10%)

 Fairly pleased

9 (47%)

3 (14%)

 Not very pleased

5 (26%)

9 (43%)

 Very disappointed

4 (21%)

7 (33%)

Responses to second satisfaction question at 4 weeks:

  

 Very pleased

4 (24%)

3 (15%)

 Fairly pleased

4 (24%)

4 (20%)

 Not very pleased

3 (18%)

6 (30%)

 Very disappointed

6 (35%)

7 (35%)

 Data missing

 

1

Responses to second satisfaction question at 12 weeks:

  

 Very pleased

4 (21%)

4 (21%)

 Fairly pleased

5 (26%)

5 (26%)

 Not very pleased

2 (11%)

5 (26%)

 Very disappointed

8 (42%)

5 (26%)

 Data missing

 

2

Responses to third satisfaction question at 2 weeks

  

  No

2 (10%)

4 (19%)

  Yes

14 (74%)

10 (48%)

  Not sure

3 (16%)

7 (33%)

Responses to third satisfaction question at 4 weeks

  

  No

4 (21%)

5 (25%)

  Yes

14 (74%)

11 (55%)

  Not sure

1 (5%)

4 (20%)

  Data missing

 

2

Responses to third satisfaction question at 12 weeks

  

  No

3 (16%)

5 (26%)

  Yes

12 (63%)

10 (53%)

  Not sure

4 (21%)

4 (21%)

  Data missing

 

2